(American Society for Biochemistry and Molecular Biology) Ovarian cancer is often diagnosed too late for effective treatment. Israeli researchers are announcing a liquid biopsy-based diagnostic protocol for ovarian cancer, with higher sensitivity than previous approaches, that may help women in high-risk populations.

Original source: https://www.eurekalert.org/pub_releases/2019-03/asfb-htc031519.php